About the role

Aplyr's Quick Take

This role is about leading a team focused on managing global medical publications for a biotech company. You'll be responsible for strategy, compliance, and execution of publication plans across various therapeutic areas, while collaborating with cross-functional teams and ensuring adherence to publication standards.

Good fit

Ideal candidates have over 12 years of experience in medical publications within biotech or pharma, with strong leadership and project management skills. A strategic thinker who thrives in a collaborative, matrixed environment will do well here.

Worth noting

The position requires a deep understanding of publication standards and compliance, which may be a steep learning curve for those without a strong background in medical communications. The role also involves significant vendor management and budget tracking.

Responsibilities:

Partners with cross-functional teams to develop the pub plans, as needed and accountable for ensuring execution of all publication plans across all TAs
Accountable for publication management system activities across all TAs
Lead a publications team and hold accountability for smooth and compliant execution of pubs across all TAs
Accountable for all training activities for all of MA with respect to publication process
Accountable for the audits and governance of all publications. Liaise with legal and compliance, as needed
Accountable for all metrics and analytics for pubs for senior leadership
Accountable to represent Global publications in all strategic meetings across all TAs
Accountable for vendor management of all publications across all TAs ensuring tracking of budget for all pubs and ensuring preferred vendor utilization for all pubs activities
Follow and stay abreast of updates to publication-related guidelines including but not limited to International Committee of Medical Journal Editors (ICJME), Good Publication Practice (GPP), CONSORT Guidelines, American Medical Association (AMA) Manual of Style, and Council of Biology Editors. Represent the organization at appropriate publication forums to elevate enterprise profile
Proactively identify operational challenges and suggest opportunities and solutions for improving operational efficiency

Qualifications:

Advanced degree in life sciences or medical discipline (PhD, PharmD, MD, or equivalent).
Valid ISMPP CMPP credential preferred
12+ years of experience in medical publications or scientific communications within the biotech/pharma industry or a medical communications agency.
Ability to think strategically in addition to experience in operationalizing scientific publication and communication strategies
Experience of working in a matrix global organization required
Demonstrated expertise in global publication planning, compliance, and governance.
Strong knowledge of publication standards (ICMJE, GPP, CONSORT, AMA) and publication tools (e.g., PubsHub/Pubs strat).
Experience with altmetrics, share of voice dashboards, and publication impact analytics including executive medical communications dashboards preferred.
Proficiency with MS Office suite (including MS Word, Excel, PowerPoint)
Excellent leadership, project management, vendor management, and stakeholder management skills; ability to influence across functions and geographies.
Strategic, collaborative, and solutions-oriented, with a proven ability to thrive in a fast-paced, global environment.
Executive presence with ability to communicate complex data persuasively and relate study results and knowledge of therapeutic area to industry-specific applications
Prior experience with change management is a strong plus

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.

Aplyr's read

CSL is a leader in biotechnology, focusing on therapies for rare diseases, with a diverse team dedicated to innovation and global impact.
Synthesized from recent postings & public sources

What's promising

•CSL has a strong focus on rare and serious diseases, offering a unique niche in the biotech industry.
•Recent hiring for senior roles indicates growth and investment in leadership and strategic capabilities.
•Global presence provides employees with opportunities for international collaboration and career development.

What to watch

•Highly specialized focus may limit opportunities for those outside the biotechnology field.
•Complex regulatory environment can pose challenges for compliance and operational efficiency.
•Rapid expansion may lead to integration challenges across diverse global teams.

Why CSL

•CSL's commitment to rare disease therapies differentiates it from broader-focused biotech firms.
•The company offers a wide array of roles, from regulatory affairs to ethics and compliance.
•CSL's global operations provide a platform for employees to engage in diverse cultural and professional experiences.

Aplyr’s read is generated by AI from public sources. Was it useful?